Home/Filings/4/0001567619-23-002391
4//SEC Filing

Johnson Michael Perkins 4

Accession 0001567619-23-002391

CIK 0000874716other

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 5:00 PM ET

Size

10.7 KB

Accession

0001567619-23-002391

Insider Transaction Report

Form 4
Period: 2023-02-08
Johnson Michael Perkins
Executive Vice President
Transactions
  • Award

    Non-Qualified Stock Option (right-to-buy)

    2023-02-08+4,3464,346 total
    Exercise: $497.43Exp: 2033-02-07Common Stock (4,346 underlying)
  • Award

    Incentive Stock Option (right-to-buy)

    2023-02-08+804804 total
    Exercise: $497.43Exp: 2033-02-07Common Stock (804 underlying)
  • Award

    Restricted Stock Unit

    2023-02-08+7044,086 total
    Common Stock (704 underlying)
Holdings
  • Common Stock

    15.8
Footnotes (5)
  • [F1]Includes 15.7999 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2022.
  • [F2]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2024.
  • [F3]Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2024.
  • [F4]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024.
  • [F5]Not applicable.

Documents

1 file

Issuer

IDEXX LABORATORIES INC /DE

CIK 0000874716

Entity typeother

Related Parties

1
  • filerCIK 0001917747

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:00 PM ET
Size
10.7 KB